0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.84%
Negative revenue growth while 3606.HK stands at 7.56%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-32.02%
Negative gross profit growth while 3606.HK is at 10.22%. Joel Greenblatt would examine cost competitiveness or demand decline.
-46.07%
Negative EBIT growth while 3606.HK is at 32.72%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-46.07%
Negative operating income growth while 3606.HK is at 42.38%. Joel Greenblatt would press for urgent turnaround measures.
-92.78%
Negative net income growth while 3606.HK stands at 52.09%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-92.42%
Negative EPS growth while 3606.HK is at 52.83%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-92.54%
Negative diluted EPS growth while 3606.HK is at 52.83%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.68%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.00%
Slight or no buyback while 3606.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
68.58%
Dividend growth under 50% of 3606.HK's 4330.73%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-13.62%
Negative OCF growth while 3606.HK is at 55.75%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-10.58%
Negative FCF growth while 3606.HK is at 113.48%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-76.95%
Negative 10Y revenue/share CAGR while 3606.HK stands at 119.15%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-60.58%
Negative 5Y CAGR while 3606.HK stands at 70.02%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-45.66%
Negative 3Y CAGR while 3606.HK stands at 57.33%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-239.91%
Negative 10Y OCF/share CAGR while 3606.HK stands at 46.69%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
39.42%
5Y OCF/share CAGR at 75-90% of 3606.HK's 45.90%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
3.16%
3Y OCF/share CAGR under 50% of 3606.HK's 30.50%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-98.14%
Negative 10Y net income/share CAGR while 3606.HK is at 177.20%. Joel Greenblatt sees a major red flag in long-term profit erosion.
132.00%
5Y net income/share CAGR similar to 3606.HK's 124.75%. Walter Schloss might see both on parallel mid-term trajectories.
107.44%
3Y net income/share CAGR 75-90% of 3606.HK's 123.15%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
-6.40%
Negative equity/share CAGR over 10 years while 3606.HK stands at 203.13%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-18.28%
Negative 5Y equity/share growth while 3606.HK is at 52.28%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
0.48%
Below 50% of 3606.HK's 22.47%. Michael Burry suspects a serious short-term disadvantage in building book value.
-3.24%
Cut dividends over 10 years while 3606.HK stands at 143.90%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
20.32%
Below 50% of 3606.HK's 67.21%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
86.50%
Below 50% of 3606.HK's 194.18%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-29.36%
Firm’s AR is declining while 3606.HK shows 5.71%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
3.59%
Inventory growth well above 3606.HK's 1.56%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-11.27%
Negative asset growth while 3606.HK invests at 0.74%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.58%
Positive BV/share change while 3606.HK is negative. John Neff sees a clear edge over a competitor losing equity.
26.20%
Debt growth far above 3606.HK's 7.04%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-29.26%
Our R&D shrinks while 3606.HK invests at 8.60%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-31.82%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.